BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19789416)

  • 21. A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy.
    Hashimoto T; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Yasuda S; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Uematsu M; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Toubaru T; Saku K; Ohshima S; Nakai M; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Heart Vessels; 2018 May; 33(5):481-488. PubMed ID: 29147787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating plasma and whole blood fatty acid compositional data into the sum of eicosapentaenoic and docosahexaenoic acid in erythrocytes.
    Stark KD; Aristizabal Henao JJ; Metherel AH; Pilote L
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jan; 104():1-10. PubMed ID: 26802936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Nakabayashi K; Jujo K; Furuki Y; Ishida I; Ando H; Shimizu M; Hagiwara N; Saito K
    Heart Vessels; 2019 May; 34(5):755-762. PubMed ID: 30430295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
    Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
    Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
    Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction.
    Matsuo N; Miyoshi T; Takaishi A; Kishinoue T; Yasuhara K; Tanimoto M; Nakano Y; Onishi N; Ueeda M; Ito H
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
    Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA.
    Patterson AC; Chalil A; Aristizabal Henao JJ; Streit IT; Stark KD
    Nutr Res; 2015 Dec; 35(12):1040-51. PubMed ID: 26500082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction.
    Burkhardt K; Kirchberger I; Heier M; Zirngibl A; Kling E; von Scheidt W; Kuch B; Meisinger C
    Eur J Prev Cardiol; 2015 Nov; 22(11):1419-26. PubMed ID: 25389071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
    Pottala JV; Garg S; Cohen BE; Whooley MA; Harris WS
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):406-12. PubMed ID: 20551373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Brismar K; Malmberg K; Mellbin L; Näsman P; Rydén L; Söderberg S; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2017 Mar; 14(2):77-87. PubMed ID: 28185529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Sumitsuji S; Kawano S; Ueda Y; Hamasaki T; Sato H; Nanto S; Hori M; Komuro I;
    Circ J; 2013; 77(2):439-46. PubMed ID: 23075765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients.
    Ueno Y; Tanaka R; Yamashiro K; Miyamoto N; Hira K; Kurita N; Sakurai M; Urabe T; Shimada K; Miyazaki T; Daida H; Hattori N
    J Atheroscler Thromb; 2018 Jul; 25(7):593-605. PubMed ID: 29199200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipstick proteinuria as a surrogate marker of long-term mortality after acute myocardial infarction.
    Ota H; Takeuchi T; Sato N; Hasebe N
    J Cardiol; 2013 Nov; 62(5):277-82. PubMed ID: 23806546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between plasma fatty acid composition and coronary artery disease.
    Itakura H; Yokoyama M; Matsuzaki M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y;
    J Atheroscler Thromb; 2011; 18(2):99-107. PubMed ID: 21099130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
    Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
    Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    Nagai T; Honda Y; Sugano Y; Nishimura K; Nakai M; Honda S; Iwakami N; Okada A; Asaumi Y; Aiba T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
    PLoS One; 2016; 11(11):e0165841. PubMed ID: 27824904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.